Skip to main content
. 2024 May 16;15:1371441. doi: 10.3389/fgene.2024.1371441

FIGURE 3.

FIGURE 3

Relative expression counting and receiver operating characteristic curve (ROC) analyses in the validation phase of five elected miRNAs. This phase consisted of 84 PCas and 84 NC serum samples. Area under the curve (AUC) of the five miRNAs were: 0.607 (95% CI: 0.529–0.681, p = 0.014 (B)) for miR-129-1-3p (A), 0.739 (95% CI: 0.665–0.803, p < 0.001 (J)) for miR-381-3p (I), 0.830 (95% CI:0.765–0.884, p < 0.001 (F)) for miR-106-5p (E), 0.688 (95% CI: 0.612–0.757, p<0.001 (D)) for miR-18a-5p (C), and 0.618 (95% CI: 0.540–0.691, p = 0.007 (H)) for miR-150-5p (G), respectively. *p < 0.05, **p < 0.01, ***p < 0.001.